Trial Profile
Clinical Trials Insight: 700052733
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2010
Price :
$35
*
At a glance
- Drugs Loratadine/montelukast (Primary) ; Loratadine; Montelukast
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 19 Jan 2010 New trial record.